Raymond James Financial’s CureVac CVAC Stock Holding History

Raymond James Financial’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23	Closed	-$125	–	5368
2025 Q2	$125	Buy	+23	New	+$91	﹤0.01%	6822

Other funds holding CVAC

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial's CVAC Position: Q3 2025 in Review

Raymond James Financial sold out of CureVac (CVAC) in Q3 2025, closing a stake of 23 shares — an estimated $125 sold.

Raymond James Financial first reported a position in CVAC in Q2 2025 and held it in 1 quarter. The position peaked at $125 in Q2 2025. 94 funds tracked by Wall St. Rank hold CVAC as of Q3 2025.

Raymond James Financial reported no remaining CureVac position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 23 CureVac shares in Q3 2025, an estimated $125.
Raymond James Financial first reported a position in CureVac in Q2 2025 and held it in 1 quarter.
Raymond James Financial's CureVac position peaked at $125 in Q2 2025.
94 funds tracked by Wall St. Rank held CureVac as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.